October 23, 2024 – BD introduced a strategic partnership with Ypsomed, a number one injection system developer, to advance self-injection options for high-viscosity biologics. The BD Neopak™

To assist this innovation, Ypsomed is increasing its YpsoMate® 2.25 two-step auto-injector platform to accommodate the brand new syringe format. This contains adapting auto-injector elements for the shorter needle, qualifying tooling and meeting, and conducting in depth engineering testing to make sure reliability. The YpsoMate auto-injector gadget includes a two-step operation: merely take away the cap and press onto the pores and skin, designed to permit folks with diminished grip or imaginative and prescient to manage their treatment simply and safely.

In a joint challenge, Ypsomed and BD pre-assessed and streamlined the combination of the BD Neopak™ (>15cP) in an auto-injector format.

Extra info